Latest Derivatives News

Page 2 of 69
Albemarle delivered a sharp third-quarter rebound, with adjusted EBITDA reaching US$645.5 million as higher lithium pricing and productivity gains outweighed lower Energy Storage volumes. The company also raised its Specialties outlook and cut planned 2026 capital spending, while flagging weaker fourth-quarter Energy Storage results.
Victor Sage
Victor Sage
5 Nov 2026
Allstate delivered stronger policy growth and higher investment income in the third quarter, but catastrophe losses and investment losses cut both GAAP and adjusted earnings. The insurer also returned about US$1.5 billion to shareholders while expanding its protection-services businesses.
Victor Sage
Victor Sage
5 Nov 2026
Taiko Critical Minerals widened its half-year loss to NZ$3.785 million as it advanced the Barrytown project, while raising NZ$9.5 million and lifting cash to NZ$7.8 million. The company now faces a December consent decision, an unconfirmed government funding offer and substantial convertible-note obligations.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Riversgold has agreed to acquire a 12-square-kilometre tenement surrounding its Northern Zone gold project near Kalgoorlie, opening the door to western extensions of known mineralisation. The A$1 million cash and share deal also creates a near-term funding requirement and adds royalties to the asset.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Marine Biomedical has secured US FDA 510(k) clearance for PearlBone, giving Orthocell a clearer path into bone regeneration through its 12% strategic stake and distribution rights. The commercial opportunity is advancing, but revenue, launch timing and definitive distribution arrangements remain undisclosed.
Ada Torres
Ada Torres
3 Nov 2026
Realty Income delivered 3.7% year-on-year growth in quarterly AFFO per share and raised its 2026 AFFO guidance, while keeping its US$10.0 billion investment target intact. The net lease REIT is also expanding its European private capital platform with KKR, but leverage and modest same-store growth remain part of the equation.
Eva Park
Eva Park
3 Nov 2026
Williams delivered higher third-quarter earnings and cash generation while keeping its 2026 guidance intact. The Momentum Midstream acquisition and a growing slate of pipeline, storage and power projects are now central to the company’s expansion case.
Maxwell Dee
Maxwell Dee
3 Nov 2026
WA Gold has reported high-grade intercepts from Abercromby, including a narrow peak of 35.21 grams per tonne gold, while launching a 7,200-metre RC campaign aimed at upgrading the project’s resource. Bullabulling has also produced a larger pipeline of exploration targets, but the company had $2.5 million in cash at quarter-end and reported 3.47 quarters of funding at its latest spending rate.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Alligator Energy has extended uranium mineralisation south of its Blackbush resource at Samphire while field recovery results feed into the project feasibility study. A $17.1 million capital raising and other receipts lifted quarter-end cash to $25.4 million.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Syntara has reported statistically significant exploratory results for its Parkinson’s-related drug SNT-4728, while advancing blood-cancer and scar studies. The quarter also brought A$4.7 million in R&D funding, but the liquidation of a former buyer threatens a facility relocation and recovery of about A$0.6 million.
Ada Torres
Ada Torres
30 Oct 2026
Invex Therapeutics has paired its proposed acquisition of Rekover Therapeutics with a $10 million equity raising to fund a Phase 2a multiple sclerosis study and its existing Exenatide programs. The biotech ended September with A$3.59 million in cash, with shareholder approval still required for the larger part of the transaction.
Ada Torres
Ada Torres
30 Oct 2026
Reece delivered 4.3% sales growth in the first quarter of FY27, powered by a 12.8% increase across Australia and New Zealand. The US remained subdued, while management flagged a cautious view of the second half.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive